Avermectin a1a
CAS: 65195-51-9
Ref. 3D-QCA19551
| 1mg | 654.00 € | ||
| 2mg | 1,019.00 € | ||
| 5mg | 1,705.00 € | ||
| 10mg | 2,664.00 € | ||
| 25mg | 5,859.00 € |
Product Information
Avermectin a1a is an analog of the antiparasitic drug ivermectin, which has been shown to have anticancer properties. It induces apoptosis in cancer cells and has been tested on various types of tumors, including those found in the urine and Chinese hamster ovary cells. Avermectin a1a has also been shown to inhibit kinase activity, particularly protein kinases such as CDK2 and GSK-3β. This inhibition leads to decreased cell proliferation and increased cell death, making it a promising candidate for cancer treatment. Additionally, Avermectin a1a has been found to be effective against indirubin-resistant human cancer cell lines, suggesting that it may have potential as an inhibitor of drug resistance in cancer therapy.
Chemical properties
Technical inquiry about: 3D-QCA19551 Avermectin a1a
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
